IndraLab
Statements
reach
"CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV‐1 infection in macrophages.It is well established that type I IFNs (T1 IFNs) can restrict acute HIV‐1 infection in vitro.1, 2, 3, 4, 5 In clinical trials treating human patients with recombinant IFN‐α2a, T1 IFNs can suppress viral replication in the absence of antiretroviral therapy (ART) in some patients.6, 7 However, this approach failed in long‐term treatment when study subjects became refractory to IFN treatment and viral loads returned to previous levels."
reach
"ISG15 has also been shown to regulate type I interferon signalling by stabilizing USP18 (ref.4) and by interacting with leucine-rich repeat-containing protein 25 (LRRC25) to mediate the autophagic degradation of retinoic acid-inducible gene I protein (RIG-I; also known as DDX58)41."